GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Emea Regulatory News (JEMA)

Share Price Information for Jpmorgan Emea (JEMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 100.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (10.526%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 100.00
JEMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Russian Court Order

25 Apr 2024 18:07

RNS Number : 1127M
JPMorgan Emerging EMEA Securities
25 April 2024
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC ('the Company' or 'JEMA')

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

Russian Court Oder

 

The Board announce that the Company's Manager has today informed the Board of the following (in italics):

 

"JEMA has been named as a defendant to civil proceedings being brought by VTB in the Russian courts which were commenced on 17 April. The claim has been brought against certain J.P. Morgan entities and relates to $439m held in a correspondent banking account with JPMCB (NY Branch) which has been blocked due to sanctions. We are not aware of any nexus between JEMA and amounts owing to VTB.

 

VTB has also applied for and obtained interim relief in the form of a freezing order in support of its claim. The order applies to the onshore funds in the bank accounts and securities owned by the relevant J.P. Morgan defendants, including JEMA, up to the value of VTB's claim. All such assets must remain frozen until further notice from the court. In response to the claim, JPMBI, the firm's Russian subsidiary, has applied to the court for the freezing order to be lifted and JPMCB has obtained an urgent order from the New York courts (the contractually agreed forum) requiring VTB to discontinue the proceedings. We will continue to monitor the proceedings and update you on relevant developments."

 

The proceedings referred to above includes JEMA's holdings in 26 Russian securities and the cash held in the Company's 'S' Account. As at 31st October 2023 the Russian securities were valued at £1.6m in the Company's accounts. The funds in the Company's 'S' Account have no value in the Company's accounts because the sum of £19.3m in the 'S' Account (as at 31st October 2023) is not recognised as an asset in the Company's balance sheet. This is because the funds in the 'S' Account were 'frozen', following the introduction of sanctions arising from Russia's invasion of Ukraine in 2022.

 

For more details about the Company's Russian securities, 'S' Account and its other assets, please see the Company's Annual Report and Financial Statements to 31st October 2023 available on the Company's website www.jpmeemeasecurities.com

 

25 April 2024

 

 For further information:

Paul Winship

Neil Martin

JPMorgan Funds Limited 020 7742 4000

 

Hugh Jonathan 

Numis Securities plc 020 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVRBRSSUSUAR
Date   Source Headline
17th Nov 202310:46 amRNSNet Asset Value(s)
16th Nov 202310:39 amRNSNet Asset Value(s)
15th Nov 202311:33 amRNSNet Asset Value(s)
14th Nov 202310:30 amRNSNet Asset Value(s)
13th Nov 202311:21 amRNSNet Asset Value(s)
13th Nov 202311:00 amRNSTen largest Investments
10th Nov 202310:14 amRNSNet Asset Value(s)
9th Nov 202311:00 amRNSNet Asset Value(s)
8th Nov 202310:28 amRNSNet Asset Value(s)
7th Nov 202310:13 amRNSNet Asset Value(s)
6th Nov 202311:56 amRNSNet Asset Value(s)
3rd Nov 202310:43 amRNSNet Asset Value(s)
2nd Nov 202311:05 amRNSNet Asset Value(s)
1st Nov 20235:33 pmRNSClosed Period Notification
1st Nov 202312:49 pmRNSNet Asset Value(s)
31st Oct 202312:06 pmRNSNet Asset Value(s)
30th Oct 202312:22 pmRNSNet Asset Value(s)
27th Oct 202311:38 amRNSNet Asset Value(s)
26th Oct 202310:46 amRNSNet Asset Value(s)
25th Oct 202311:12 amRNSNet Asset Value(s)
24th Oct 202311:00 amRNSNet Asset Value(s)
23rd Oct 202311:20 amRNSNet Asset Value(s)
20th Oct 20231:51 pmRNSNet Asset Value(s)
19th Oct 202310:51 amRNSNet Asset Value(s)
18th Oct 202311:01 amRNSNet Asset Value(s)
17th Oct 202311:13 amRNSNet Asset Value(s)
16th Oct 202310:49 amRNSNet Asset Value(s)
13th Oct 202311:27 amRNSNet Asset Value(s)
12th Oct 20234:06 pmRNSTen Largest Investments
12th Oct 202311:09 amRNSNet Asset Value(s)
11th Oct 20236:04 pmRNSUpdate on Tender Application
11th Oct 202311:06 amRNSNet Asset Value(s)
10th Oct 202312:11 pmRNSHolding(s) in Company
10th Oct 202311:39 amRNSNet Asset Value(s)
9th Oct 202311:22 amRNSNet Asset Value(s)
6th Oct 202311:43 amRNSNet Asset Value(s)
5th Oct 202310:56 amRNSNet Asset Value(s)
4th Oct 202311:44 amRNSNet Asset Value(s)
3rd Oct 202311:25 amRNSNet Asset Value(s)
2nd Oct 202312:45 pmRNSNet Asset Value(s)
28th Sep 202311:30 amRNSNet Asset Value(s)
27th Sep 202310:56 amRNSNet Asset Value(s)
26th Sep 202311:05 amRNSNet Asset Value(s)
25th Sep 202312:07 pmRNSNet Asset Value(s)
22nd Sep 202311:04 amRNSNet Asset Value(s)
21st Sep 202311:15 amRNSNet Asset Value(s)
20th Sep 202310:38 amRNSNet Asset Value(s)
19th Sep 202310:36 amRNSNet Asset Value(s)
18th Sep 202311:07 amRNSNet Asset Value(s)
15th Sep 202311:32 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.